Sharp drops
Stocks down hard from their 20-day high, each diagnosed against validated event history.
This is a diagnosis, not a buy call. This system has no validated bullish signal — every validated event type drifts negative — so it never asserts a stock will rise. “Possible overreaction” flags a rebound candidate pending backtest validation only.
Rebound backtest
Does buying after such a drop pay off? Fixed rule, out-of-sample, net of costs.
Not enough clean price history to validate a rebound edge yet — refresh recent prices to build it. Until then “possible overreaction” stays an observation, not a signal.
Loading…